Coherus Oncology (CHRS) Asset Utilization Ratio (2014 - 2026)

Coherus Oncology has disclosed Asset Utilization Ratio across 13 years of filings, most recently posting 0.22 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio rose 185.41% year-over-year to 0.22; the TTM figure through Jun 2026 stood at 0.22 (up 185.41% YoY), while the FY2025 annual figure was 0.12, up 143.74% from the prior year.
• Asset Utilization Ratio came in at 0.22 for Q2 2026 at Coherus Oncology, up from 0.18 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.48 in Q2 2022 to a low of 0.06 in Q4 2024.
• Average Asset Utilization Ratio over 5 years is 0.28, with a median of 0.29 recorded in 2024.
• Year-over-year, Asset Utilization Ratio slumped 86.95% in 2024 and soared 185.41% in 2026.
• Over 5 years, Asset Utilization Ratio stood at 0.41 in 2022, then grew by 3.65% to 0.42 in 2023, then tumbled by 86.95% to 0.06 in 2024, then soared by 96.66% to 0.11 in 2025, then surged by 104.7% to 0.22 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.22 in Q2 2026, 0.18 in Q1 2026, and 0.11 in Q4 2025.